Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous

Monica Verdoia1, Filippo Viglione2, Annalisa Boggio3

  • 1Division of Cardiology, Ospedale degli Infermi, ASL Biella, Biella, Italy.

Vascular Pharmacology
|July 18, 2021
PubMed

Insights

Low vitamin D levels in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI) are linked to poorer epicardial reperfusion. This highlights a potential role for vitamin D in STEMI outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Background:

  • Vitamin D has known cardioprotective effects, including antioxidant and anti-inflammatory properties.
  • Previous research links vitamin D deficiency to worse outcomes in coronary artery disease (CAD), particularly in ST-segment elevation myocardial infarction (STEMI) patients.
  • Limited data exist on vitamin D levels' association with angiographic findings and reperfusion in STEMI patients treated with primary percutaneous coronary intervention (pPCI).

Purpose of the Study:

  • To investigate the relationship between vitamin D levels and angiographic findings, specifically epicardial reperfusion.
  • To assess the association between vitamin D status and procedural outcomes in STEMI patients undergoing pPCI.

Main Methods:

  • A cohort of 450 STEMI patients treated with pPCI were analyzed.
  • Serum 25(OH)D levels were measured upon admission; hypovitaminosis D was defined as <10 ng/ml.
  • Patients were stratified into tertiles based on vitamin D levels, and associations with clinical, angiographic, and procedural data were examined.

Main Results:

  • Lower vitamin D levels correlated with increased diuretic use, higher white blood cell counts and glycemia, fewer bifurcation lesions, and smaller target vessel diameter.
  • While pre-procedural TIMI flow was similar, patients with lower vitamin D showed a significantly higher rate of impaired epicardial reperfusion (adjusted OR=2.6).
  • Impaired reperfusion in lower vitamin D groups necessitated increased use of adenosine and glycoprotein IIb/IIIa inhibitors.

Conclusions:

  • Low vitamin D levels are independently associated with impaired epicardial reperfusion in STEMI patients undergoing pPCI.
  • Further research is warranted to explore the prognostic implications of hypovitaminosis D and potential therapeutic interventions in this patient population.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
54
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
116
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
182
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
97
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.1K